Individual | Metabolite Levels Relative to Gray Matter | Metabolite Ratios | ||||
---|---|---|---|---|---|---|
Cho | Cr | NAA | NAA/Cho | NAA/Cr | Cho/Cr | |
A. Frontal white matter | ||||||
Patient 1 | 1.17 | 1.19 | 0.84 | 1.16 | 1.63 | 1.41 |
Patient 2 | 1.28 | 1.01 | 1.02 | 1.62 | 2.63 | 1.63 |
Patient 3 | 1.68 | 0.95 | 0.87 | 1.27 | 2.32 | 1.83 |
Control subject 1 | 1.64 | 1.00 | 0.81 | 1.09 | 2.17 | 2.00 |
Control subject 2 | 1.51 | 0.92 | 0.94 | 1.26 | 2.57 | 2.03 |
Control subject 3 | 1.14 | 0.61 | 0.85 | 1.89 | 4.17 | 2.21 |
B. Centrum semiovale | ||||||
Patient 1 | 1.38 | 1.11 | 0.74 | 0.87 | 1.55 | 1.79 |
Patient 2 | 1.28 | 0.95 | 0.89 | 1.42 | 2.43 | 1.71 |
Patient 3 | 1.61 | 1.02 | 0.96 | 1.46 | 2.38 | 1.63 |
Control subject 1 | 1.35 | 0.81 | 0.82 | 1.34 | 2.71 | 2.03 |
Control subject 2 | 1.38 | 0.85 | 0.99 | 1.46 | 2.90 | 1.99 |
Control subject 3 | 1.55 | 0.85 | 0.99 | 1.61 | 3.46 | 2.15 |
C: Parietal white matter | ||||||
Patient 1 | 1.31 | 1.03 | 0.61 | 0.76 | 1.37 | 1.81 |
Patient 2 | 1.13 | 0.97 | 0.93 | 1.69 | 2.50 | 1.48 |
Patient 3 | 1.65 | 1.03 | 0.81 | 1.20 | 1.98 | 1.66 |
Control subject 1 | 1.42 | 0.92 | 0.84 | 1.29 | 2.42 | 1.87 |
Control subject 2 | 1.42 | 0.84 | 0.96 | 1.37 | 2.84 | 2.07 |
Control subject 3 | 1.45 | 0.66 | 0.84 | 1.46 | 3.80 | 2.60 |
D: Parieto-occipital gray matter* | ||||||
Patient 1 | NA | NA | NA | 1.61 | 2.31 | 1.43 |
Patient 2 | NA | NA | NA | 2.03 | 2.60 | 1.28 |
Patient 3 | NA | NA | NA | 2.44 | 2.52 | 1.04 |
Control subject 1 | NA | NA | NA | 2.19 | 2.67 | 1.22 |
Control subject 2 | NA | NA | NA | 2.03 | 2.50 | 1.23 |
Control subject 3 | NA | NA | NA | 2.52 | 2.99 | 1.18 |
Note.—Patient 1 was aged 2 years 5 months; patient 2, 3 years, 8 months; patient 3, 7 years, 6 months; control subject 1, 1 year, 9 months; control subject 2, 3 years, 2 months; and control subject 3, 7 years, 0 months.
* NA indicates not applicable.